97333 ⎘
Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a MBP (maltose binding protein)-tag
TREATMENT METHOD
#2PROTEIN DOUBLE-SHELL NANOSTRUCTURES AND THEIR USE
#3LEGIONAMINIC ACID GLYCOSYLTRANSFERASES FOR CHEMOENZYMATIC SYNTHESIS OF GLYCANS AND GLYCOCONJUGATES
#4ENGINEERED RECOMBINANT PROTEIN-BINDING DOMAINS AS DETECTION REAGENTS
#5NLRP3 Variants & Library Screen for NLRP3 Inhibitors with the Same
#6COMPOSITIONS AND METHODS FOR SOLUBILIZING GLYCOSYLTRANSFERASES
#7BACTERIAL COLICIN-IMMUNITY PROTEIN PROTEIN PURIFICATION SYSTEM
#8Nucleic Acid Synthesis and Sequencing Using Tethered Nucleoside Triphosphates
#9PROTEIN SCREENING AND DETECTION METHOD
#10A GENETICALLY ENGINEERED BACTERIUM AND A PREPARATION METHOD AND USE THEREOF
#11COMPOSITIONS, METHODS AND/OR KITS COMPRISING A RECOMBINANT HUMAN CD38-EXTRACELLULAR DOMAIN
#12HORN FLY VACCINE COMPOSITIONS AND METHODS OF MAKING SAME
#13COMPOSITIONS, METHODS AND/OR KITS COMPRISING A RECOMBINANT HUMAN CD38-EXTRACELLULAR DOMAIN
#14COMPOSITIONS, METHODS AND/OR KITS COMPRISING A RECOMBINANT HUMAN CD38-EXTRACELLULAR DOMAIN
#15Genetically encoded biosensors
#16HIGHER PERFORMANCE PROTEASES FOR SCARLESS PEPTIDE TAG REMOVAL
#17PROTEIN DOUBLE-SHELL NANOSTRUCTURES AND THEIR USE
#18Protein for rapid, efficient capture of antigens
#19INTRACELLULAR MOLECULAR RECORDING AND MEMORY VIA PROTEIN SELF-ASSEMBLY
#20CHIMERIC FUSIONS BETWEEN C4-BINDING PROTEIN C-TERMINAL SEGMENT AND ANGIOPOIETIN-1 FIBRINOGEN-LIKE DOMAIN AS ANGIOPOIETIN MIMETICS AND TIE2 AGONISTS TO TREAT VASCULAR DISEASES
#21NOVEL INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE
#22Polymerase-tethered nucleotides for nucleic acid synthesis
#23Nucleic acid synthesis and sequencing using tethered nucleoside triphosphates
#24Proteins and peptide tags with enhanced rate of spontaneous isopeptide bond formation and uses thereof
#25N- and C-terminal tandem tag system for purification
#26Genetically encoded biosensors
#27POLYPEPTIDE TARGETING APTAMERS FOR CHARACTERIZATION, CAPTURE, AND CLINICAL MANAGEMENT OF CIRCULATING TUMOR CELLS
#28Baicalein- and Scutellarein- Synthesizing Microorganism, Preparation Method and Applications Thereof
#29Compositions, methods and/or kits comprising a recombinant human CD38- extracellular domain
#30SOLUBILITY ENHANCING PROTEIN EXPRESSION SYSTEMS
#31Hornfly vaccine methods
#32Bacterial colicin-immunity protein protein purification system
#33Genetically encoded biosensors
#34BRCA2-mediated purification of recombinase protein
#35NOVEL INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE
#36SIRP-gamma polypeptide compositions and treatment of cancer
#37PHOSPHOTRIESTERASE ENZYME TETHERED MONOMER
#38A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES
#39Proteins and peptide tags with enhanced rate of spontaneous isopeptide bond formation and uses thereof
#40Neuroprotective agents derived from spider venom peptides
#41Genetically encoded biosensors
#42Amino acid sequence presenting fusion polypeptide and its use
#43Method for expressing and purifying soluble protein of CRM197
#44Methods for protein ligation and uses thereof
#45Cas9 variants and methods of use thereof
#46GENETICALLY ENCODED BIOSENSORS
#47Protein screening and detection method
#48Compositions and methods comprising permuted protein tags for facilitating overexpression, solubility, and purification of target proteins
#49Polypeptide targeting aptamers for characterization, capture, and clinical management of circulating tumor cells
#50Fusion proteins comprising an aldolase enzyme joined to a maltose binding protein
#51Methods of transcription activator like effector assembly
#52Botulinum neurotoxin and its derivatives
#53Protein for rapid, efficient capture of antigens
#54Polymerase-tethered nucleoside triphosphates for use in nucleic acid synthesis
#55IN SITU AND IN VIVO ANALYSIS OF CHROMATIN INTERACTIONS BY BIOTINYLATED DCAS9 PROTEIN
#56Compositions and methods for inhibiting Wnt signaling
#57Genetically encoded biosensors
#58APPLICATION OF ZN7MT3 AND ITS DERIVATIVES IN THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE
#59Bacterial colicin-immunity protein protein purification system
#60FLUOROUS COMPOUND, METHOD OF PREPARING FLUOROUS TAGGED PROTEIN, AND METHOD OF IMMOBILIZING PROTEIN
#61Stabilized reverse transcriptase fusion proteins
#62COMPOSITIONS AND METHODS FOR DELIVERING BIOTHERAPEUTICS
#63STABILIZED REVERSE TRANSCRIPTASE FUSION PROTEINS
#64In vitro assembly of bacterial microcompartments
#65Composition for improving skin conditions comprising a fragment of human heat shock protein 90A as an active ingredient
#66Cas9 variants and methods of use thereof
#67Endoglin polypeptides and uses thereof
#68AXMI115 variant insecticidal gene and methods for its use
#69Polypeptide having chemokine activity and uses thereof
#70Genetically encoded biosensors
#71Neuroprotective agents derived from spider venom peptides
#72SIRP-gamma polypeptide compositions and methods of use
#73High affinity CD47 analogs
#74Cell-directed synthesis of multifunctional nanopatterns and nanomaterials
#75BRCA2 mediated protein purification recombinase
#76Genetically encoded biosensors
#77BMP peptides and methods of use
#78Insecticidal proteins and methods for their use
#79HIGH AFFINITY METAL-OXIDE BINDING PEPTIDES WITH REVERSIBLE BINDING
#80Polypeptide having a polyester degrading activity and uses thereof
#81HIGHER PERFORMANCE PROTEASES FOR SCARLESS TAG REMOVAL
#82Treatment method
#83Polymer-protein core-shell particles as effective vaccine delivery vehicles and treatments methods using the same
#84Precipitable peptides
#85Monomeric avidin-like proteins with stable biotin binding ability
#86Method and composition for determining specific antibody responses to species of filovirus
#87SIRP polypeptide compositions and methods of use
#88Methods of transcription activator like effector assembly
#89Stabilized reverse transcriptase fusion proteins
#90Expression system for producing protein having a N-terminal pyroglutamate residue
#91NEW METHODS TO PRODUCE ACTIVE TERT
#92AXMI115 variant insecticidal gene and methods for its use
#93Amino acid sequence presenting fusion polypeptide and its use
#94Antibody specifically binding to insulin-like growth factor-1
#95IMMUNOGENIC COMPOSITION COMPRISING ALPHA-HEMOLYSIN OLIGOPEPTIDES
#96Method and compositions for treatment of calcineurin-related diseases
#97METHOD FOR SPECIFICALLY ISOLATING NUCLEIC ACIDS
#98Norrin Mutant Polypeptides, Methods of Making and Uses Thereof
#99AXMI115 variant insecticidal gene and methods for its use
#100Endoglin polypeptides and uses thereof
#101High affinity metal-oxide binding peptides with reversible binding
#102Reversible chemoenzymatic labeling of native and fusion carrier protein motifs
#103SCYTODES VENOM FIBER PEPTIDES, NUCLEIC ACIDS AND METHODS OF MAKING AND USING
#104Endoglucanase variants
#105Cell-directed synthesis of multifunctional nanopatterns and nanomaterials
#106Genetically encoded biosensors
#107BLID; a novel protein domain for interaction with the Bcl-2 family of proteins. Applications in oncology
#108Method for producing recombinant prothrombin, vector DNA, and reagent kit
#109HSA-related compositions and methods of use
#110Molecule for treating an inflammatory disorder
#111Precipitable peptides
#112Amino acid sequence presenting fusion polypeptide and its use
#113GPCR comprising an IC2 insertion
#114Antibody specifically binding to insulin-like growth factor-1
#115Quantitative standard for mass spectrometry of proteins
#116AXMI238 toxin gene and methods for its use
#117Insecticidal proteins and methods for their use
#118Peptides that modulate complex SASPase-FLG2
#119BLID; a novel protein domain for interaction with the Bcl-2 family of proteins
#120Molecular switches and methods for making and using the same
#121Expression and purification of fusion protein with multiple MBP tags
#122PmST2 enzyme for chemoenzymatic synthesis of α-2-3-sialylglycolipids
#123HSA-related compositions and methods of use
#124SUMO-SPECIFIC AFFINITY TAG
#125Compositions and methods for preparing recombinant MG53 and methods for optimizing same
#126recombinant collagenases and method for the manufacture thereof
#127GPCR comprising an IC2 insertion
#128Cytokine zalpha11 ligand
#129Endoglucanase variants
#130Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand
#131Method for producing serratia marcescens nuclease using a bacillus expression host
#132CONSTRUCTS FOR DELIVERY OF THERAPEUTIC AGENTS TO NEURONAL CELLS
#133Solubilization and purification of a target protein fused to a mutant maltose-binding protein
#134Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies
#135Stabilized reverse transcriptase fusion proteins
#136Intracellular production of a nuclease
#137Protein purification tags and uses thereof
#138Solubilization and purification of a target protein fused to a mutant maltose-binding protein
#139Targeted modification of chromatin structure
#140Cytokine zalpha11 ligand antibodies
#141CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#142Photoswitchable method for the ordered attachment of proteins to surfaces
#143High affinity metal-oxide binding peptides with reversible binding
#144SOLUBLE AND MEMBRANE ANCHORED FORMS OF LASSA VIRUS SUBUNIT PROTEINS
#145Cytokine zalpha11 ligand antibodies
#146Directed engagement of activating Fc receptors
#147Method for the immobilization of biologically active polypeptides by using maltose binding protein
#148Solubilization and purification of a target protein fused to a mutant maltose-binding protein
#149SUMO fusion protein expression system for producing native proteins
#150Constructs for delivery of therapeutic agents to neuronal cells
#151Target substance capturing molecule
#152Environmentally stable sensors and methods of using the same
#153NOVEL P-SELECTIN LIGAND PROTEIN
#154P-selectin ligand protein
#155Targeted modification of chromatin structure
#156Recombinant Polypeptides and Methods for Detecting and/or Quantifying Autoantibodies Against Tsh Receptor
#157Nucleic acids encoding P-selectin ligand fusion proteins
#158METHODS AND MATERIALS FOR TREATING INFLAMMATORY CONDITIONS
#159Cell Free Assay for Determining a Substance of Interest and Molecular Complexes Used Therefore
#160Delivery method for the tumor-specific apoptosis-inducing activity of apoptin
#161Intracellular production of a nuclease
#162Photoswitchable method for the ordered attachment of proteins to surfaces
#163Engineered stimulus-responsive switches
#164Cytokine zalpha11 ligand fusion proteins
#165CYTOKINE ZALPHA11 LIGAND
#166CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#167CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#168Cytokine zalpha11 ligand fusion proteins
#169Cytokine zalpha11 ligand fusion proteins
#170Method for expanding hematopoietic cells using cytokine zalpha11 ligand
#171Cytokine zalpha11 ligand antibodies and methods of use
#172Methods of using cytokine zalpha11 ligand
#173CYTOKINE ZALPHA11 LIGAND FUSION PROTEINS
#174Cytokine zalpha11 ligand fusion proteins
#175Method of use of cytokine ZALPHA11 ligand
#176CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#177Cytokine zalpha11 ligand antibodies
#178HIV gp41 HR2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus
#179Bacterial ligand-binding sensor
#180Targeted modification of chromatin structure
#181Processing for producing and crystallizing G-protein coupled receptors
#182Streptavidin-binding peptides and uses thereof
#183Molecular switches and methods for making and using the same
#184Intein-mediated protein ligation of expressed proteins
#185Photoswitchable method for the ordered attachment of proteins to surfaces
#186Zinc finger protein derivatives and methods therefor
#187Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases